Bausch + Lomb (BLCO) Financial statements
Company Profile
| Dec 2024 | Dec 2023 | Dec 2022 | ||
|---|---|---|---|---|
| Total Revenue | ||||
| Cost of Revenue | ||||
| Gross Profit | ||||
| Gross Profit Margin (%) | ||||
| R&D Expense | ||||
| SG&A Expense | ||||
| Total Operating Expenses | ||||
| Operating Income or Loss | ||||
| Operating Margin (%) | ||||
| Interest Expense | ||||
| Total Other Income/Expenses | ||||
| Income Before Tax | ||||
| Income Tax Expense | ||||
| Income from Continuing Ops. | ||||
| Net Income | ||||
| Net Profit Margin (%) | ||||
| Net Income Available to Common Shareholders | ||||
| Basic EPS | ||||
| Diluted EPS | ||||
| Basic Average Shares | ||||
| Diluted Average Shares |
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ||||||||||||||||
| Cost of Revenue | ||||||||||||||||
| Gross Profit | ||||||||||||||||
| Gross Profit Margin (%) | ||||||||||||||||
| R&D Expense | ||||||||||||||||
| SG&A Expense | ||||||||||||||||
| Total Operating Expenses | ||||||||||||||||
| Operating Income or Loss | ||||||||||||||||
| Operating Margin (%) | ||||||||||||||||
| Interest Expense | ||||||||||||||||
| Total Other Income/Expenses | ||||||||||||||||
| Income Before Tax | ||||||||||||||||
| Income Tax Expense | ||||||||||||||||
| Income from Continuing Ops. | ||||||||||||||||
| Net Income | ||||||||||||||||
| Net Profit Margin (%) | ||||||||||||||||
| Net Income Available to Common Shareholders | ||||||||||||||||
| Basic EPS | ||||||||||||||||
| Diluted EPS | ||||||||||||||||
| Basic Average Shares | ||||||||||||||||
| Diluted Average Shares |
| Dec 2024 | Dec 2023 | Dec 2022 | ||
|---|---|---|---|---|
| Current Assets | ||||
| Cash & Cash Equivalents | ||||
| Marketable Securities | ||||
| Receivables | ||||
| Inventories | ||||
| Other Current Assets | ||||
| Total Current Assets | ||||
| Non-Current Assets | ||||
| Marketable Securities | ||||
| PPE Net | ||||
| Intangibles inc. Goodwill | ||||
| Other Non-Current Assets | ||||
| Total Non-Current Assets | ||||
| Total Assets | ||||
| Current Liabilities | ||||
| Accounts Payable | ||||
| Deferred Revenues | ||||
| Debt, Current | ||||
| Accrued Liabilities | ||||
| Other Current Liabilities | ||||
| Total Current Liabilities | ||||
| Non-Current Liabilities | ||||
| Deferred Revenues | ||||
| Debt, Non-Current | ||||
| Other Non-Current Liabilities | ||||
| Total Non-Current Liabilities | ||||
| Total Liabilities | ||||
| Shareholders' Equity | ||||
| Common Stock | ||||
| Additional Paid-In Capital | ||||
| Retained Earnings | ||||
| Other Shareholders' Equity | ||||
| Total Shareholders' Equity | ||||
| Total Liabilities & Shareholders' Equity |
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||||||
| Cash & Cash Equivalents | ||||||||||||||||
| Marketable Securities | ||||||||||||||||
| Receivables | ||||||||||||||||
| Inventories | ||||||||||||||||
| Other Current Assets | ||||||||||||||||
| Total Current Assets | ||||||||||||||||
| Non-Current Assets | ||||||||||||||||
| Marketable Securities | ||||||||||||||||
| PPE Net | ||||||||||||||||
| Intangibles inc. Goodwill | ||||||||||||||||
| Other Non-Current Assets | ||||||||||||||||
| Total Non-Current Assets | ||||||||||||||||
| Total Assets | ||||||||||||||||
| Current Liabilities | ||||||||||||||||
| Accounts Payable | ||||||||||||||||
| Deferred Revenues | ||||||||||||||||
| Debt, Current | ||||||||||||||||
| Accrued Liabilities | ||||||||||||||||
| Other Current Liabilities | ||||||||||||||||
| Total Current Liabilities | ||||||||||||||||
| Non-Current Liabilities | ||||||||||||||||
| Deferred Revenues | ||||||||||||||||
| Debt, Non-Current | ||||||||||||||||
| Other Non-Current Liabilities | ||||||||||||||||
| Total Non-Current Liabilities | ||||||||||||||||
| Total Liabilities | ||||||||||||||||
| Shareholders' Equity | ||||||||||||||||
| Common Stock | ||||||||||||||||
| Additional Paid-In Capital | ||||||||||||||||
| Retained Earnings | ||||||||||||||||
| Other Shareholders' Equity | ||||||||||||||||
| Total Shareholders' Equity | ||||||||||||||||
| Total Liabilities & Shareholders' Equity |
| Dec 2024 | Dec 2023 | Dec 2022 | ||
|---|---|---|---|---|
| Cash Flows from Operating Activities | ||||
| Net Income | ||||
| Depreciation & Amortization | ||||
| Deferred Income Taxes | ||||
| Stock Based Compensation | ||||
| Accounts Receivable | ||||
| Inventory | ||||
| Accounts Payable | ||||
| Deferred Revenue | ||||
| Other Non-Cash | ||||
| Operating Cash Flow | ||||
| Cash Flows from Investing Activities | ||||
| PPE Investments | ||||
| Net Acquisitions | ||||
| Purchase of Investments | ||||
| Sale of Investments | ||||
| Other Investing Activity | ||||
| Investing Cash Flow | ||||
| Cash Flows from Financing Activities | ||||
| Debt Issued | ||||
| Proceeds from Debt Repayment | ||||
| Debt Repayment | ||||
| Proceeds from Sale of Equity | ||||
| Equity Repurchased | ||||
| Dividend Paid | ||||
| Other Financing Activity | ||||
| Financing Cash Flow | ||||
| Cash Position | ||||
| Beginning Cash Position | ||||
| End Cash Position | ||||
| Change in Cash | ||||
| Free Cash Flow | ||||
| Operating Cash Flow | ||||
| Capital Expenditure | ||||
| Free Cash Flow |
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flows from Operating Activities | ||||||||||||||||
| Net Income | ||||||||||||||||
| Depreciation & Amortization | ||||||||||||||||
| Deferred Income Taxes | ||||||||||||||||
| Stock Based Compensation | ||||||||||||||||
| Accounts Receivable | ||||||||||||||||
| Inventory | ||||||||||||||||
| Accounts Payable | ||||||||||||||||
| Deferred Revenue | ||||||||||||||||
| Other Non-Cash | ||||||||||||||||
| Operating Cash Flow | ||||||||||||||||
| Cash Flows from Investing Activities | ||||||||||||||||
| PPE Investments | ||||||||||||||||
| Net Acquisitions | ||||||||||||||||
| Purchase of Investments | ||||||||||||||||
| Sale of Investments | ||||||||||||||||
| Other Investing Activity | ||||||||||||||||
| Investing Cash Flow | ||||||||||||||||
| Cash Flows from Financing Activities | ||||||||||||||||
| Debt Issued | ||||||||||||||||
| Proceeds from Debt Repayment | ||||||||||||||||
| Debt Repayment | ||||||||||||||||
| Proceeds from Sale of Equity | ||||||||||||||||
| Equity Repurchased | ||||||||||||||||
| Dividend Paid | ||||||||||||||||
| Other Financing Activity | ||||||||||||||||
| Financing Cash Flow | ||||||||||||||||
| Cash Position | ||||||||||||||||
| Beginning Cash Position | ||||||||||||||||
| End Cash Position | ||||||||||||||||
| Change in Cash | ||||||||||||||||
| Free Cash Flow | ||||||||||||||||
| Operating Cash Flow | ||||||||||||||||
| Capital Expenditure | ||||||||||||||||
| Free Cash Flow |